Gohealth, INC Form 4 insider transactions

Brad Burd, Chief Legal Officer of GoHealth, Inc., reported multiple transactions in common stock on July 21, 2026.

Brendan Richard Shanahan, Chief Financial Officer of GoHealth, Inc., reported a transaction in 237,275 shares of common stock on July 21, 2026.

Vijay Kotte, Chief Executive Officer and a Director of GoHealth, Inc., reported multiple transactions in common stock on July 21, 2026.

GoHealth, Inc.'s Chief Financial Officer, Brendan Shanahan, disposed of 12,725 shares of Class A Common Stock to cover tax liabilities from restricted stock unit vesting.

GoHealth's Chief Operating Officer, Mike Hargis, disposed of 5,545 Class A Common Stock shares to cover tax withholding obligations related to RSU vesting.

GoHealth CEO Vijay Kotte was granted 218,551 restricted stock units and corrected a previous overstatement of beneficial ownership.

Brad Burd, Chief Legal Officer of GoHealth, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

GoHealth's CEO, Vijay Kotte, disposed of 24,612 shares of Class A Common Stock on April 10, 2025, to cover tax withholding obligations related to vesting restricted stock units.

GoHealth CEO Vijay Kotte received 500,000 shares of restricted stock that vested immediately and disposed of 221,500 shares to cover tax obligations.

GoHealth CEO Vijay Kotte reports the acquisition and disposal of Class A Common Stock, including shares withheld for tax obligations and a grant of restricted stock units.

GoHealth's Chief Legal Officer, Brad Burd, reports the acquisition and disposal of Class A Common Stock due to tax obligations and a grant of restricted stock units.

GoHealth's Chief Operating Officer, Mike Hargis, reports the acquisition and disposal of Class A Common Stock, including shares withheld for tax obligations and a grant of restricted stock units.

GoHealth's CFO, Brendan Richard Shanahan, was granted 100,000 shares of Class A Common Stock on April 1, 2025, as part of a restricted stock unit grant.

Chief Legal Officer of GoHealth, Brad Burd, reports the disposal of 1,099 shares to cover tax obligations related to vesting restricted stock units.

GoHealth's Chief Operating Officer, Mike Hargis, disposed of 6,238 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

GoHealth's Chief Financial Officer, Brendan Richard Shanahan, was granted 150,000 restricted stock units on November 1, 2024, which vest in three annual installments starting November 1, 2025.

GoHealth's Chief Operating Officer, Mike Hargis, disposed of 5,545 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

GoHealth's Chief Operating Officer, Mike Hargis, disposed of shares to cover tax obligations related to vesting restricted stock units.

Director Timothy Alan Wheatley received a grant of 9,906 restricted stock units in GoHealth, Inc.

Karolina Hanna Hilu, a director at GoHealth, Inc., acquired 14,605 shares of Class A Common Stock through a restricted stock unit grant on June 12, 2024.

Director David Fisher acquired 24,342 shares of GoHealth, Inc. Class A Common Stock at a price of $10.27 per share on June 12, 2024, and also received restricted stock units vesting quarterly starting September 12, 2024.

Director Alexander E. Timm acquired 14,605 shares of GoHealth, Inc. Class A Common Stock on June 12, 2024, at a price of $10.27 per share.

Interim CFO of GoHealth, Katherine OHalloran, reports the acquisition of 25,000 shares of Class A Common Stock via a restricted stock unit grant.

Brad Burd, Chief Legal Officer of GoHealth, Inc., reports the disposal of 814 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

GoHealth's Chief Financial Officer, Jason Schulz, disposed of 3,145 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

GoHealth CEO Vijay Kotte disposed of 16,278 shares of Class A Common Stock on April 10, 2024, to cover tax obligations related to vesting restricted stock units.

GoHealth's CFO, Jason Schulz, reports the grant of restricted stock units and stock options in a recent SEC filing.

GoHealth's CEO, Vijay Kotte, reported the acquisition of restricted stock units and stock options in a recent Form 4 filing with the SEC.

GoHealth's Chief Operating Officer, Mike Hargis, was granted 100,000 restricted stock units on April 1, 2024, which vest in three annual installments starting April 1, 2025.

GoHealth's Chief Legal Officer, Brad Burd, was granted 50,000 restricted stock units on April 1, 2024, which vest in three annual installments starting April 1, 2025.